Latest Breaking News On - Olvimulogene nanivacirepvec - Page 1 : comparemela.com

Genelux Says FDA Grants Fast Track Designation For Olvi-Vec To Treat Ovarian Cancer

Immuno-oncology company Genelux Corp. (GNLX) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene nanivacirepvec) for the treatment of patients with platinum resistant/refractory ovarian cancer.

United statesAcorn baking coDrug administrationBlack fridayCountry gift basketsAcorn bakingCyber mondayUs food and drug administrationMmuno oncology company geneluxLvi vecOlvimulogene nanivacirepvecNprime gog 3076

Genelux Corporation Announces Publication of Phase I Trial Results of Intrapleural Administration of Olvi-Vec in Patients with Malignant Pleural Effusion from Mesothelioma, Lung or Breast Cancers in Frontiers in Immunology

Genelux Corporation Announces Publication of Phase I Trial Results of Intrapleural Administration of Olvi-Vec in Patients with Malignant Pleural Effusion from Mesothelioma, Lung or Breast Cancers in Frontiers in Immunology
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMemorial sloan kettering cancer centerOlvimulogene nanivacirepvec olvi vecSloan ketteringAnkit bhargavaThomas zindrickExchange commissionAllele communicationsGenelux corporationSecurities exchangeCorporation announces publicationPhasei trial resultsIntrapleural administrationMalignant pleural effusionBreast cancers

Genelux (GNLX) Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial

Genelux (GNLX) Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Robertw hollowayOlvimulogene nanivacirepvecOlvimulogene nanivacirepvec olvi vecJack westAnkit bhargavaThomas zindrickSecurities exchangeGenelux corporationAllele communicationsGynecologic oncology program at adventhealth cancer instituteExchange commissionOriginal investigationDisease control rateMedical directorGynecologic oncology programAdventhealth cancer institute

Genelux and Newsoara Announce Collaboration and License Agreement for Oncolytic Immunotherapies

Genelux and Newsoara Announce Collaboration and License Agreement for Oncolytic Immunotherapies
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Hong kongOlvimulogene nanivacirepvec olvi vecBenny liThomas zindrickTiberend strategic advisors incGenelux corporationPrnewswire genelux corporationNewsoara biopharma co ltdGreater chinaOlvimulogene nanivacirepvecStrategic advisors